Patent directory · USPTO A61K / A61P
Patents matching “formulation”
865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12133914
Hydrocortisone oral liquid formulations
granted -
US 12128092
Lyophilized factor IX formulations
granted -
US 12128109
Muscle targeting complexes and formulations for treating dystrophinopathies
granted -
US 12123035
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12115149
Formulations, methods, kits, and dosage forms
granted -
US 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12115254
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12110520
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12102671
Method of vaccination with an attenuated RSV vaccine formulation
granted -
US 12104185
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12102637
Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
granted -
US 12104184
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12090139
Formulations comprising triptan compounds
granted -
US 12091692
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12083122
Laureth-4 containing topical formulations
granted -
US 12083229
Ocular drug delivery formulation
granted -
US 12083227
Solid pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
granted -
US 12077502
Formulations of T-type calcium channel modulators and methods of use thereof
granted -
US 12077593
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 12071516
Polymeric stabilizing formulations
granted -
US 12070502
Process for reducing subvisible particles in a pharmaceutical formulation
granted -
US 12064398
Parenteral formulations
granted -
US 12064516
Pharmaceutical formulations and uses thereof
granted -
US 12060590
PH20 polypeptide variants, formulations and uses thereof
granted